Cosmetic Supply Chain Transparency Act of 2025
Summary
What This Bill Does
The Cosmetic Supply Chain Transparency Act builds a detailed information chain inside the Federal Food, Drug, and Cosmetic Act. It preserves stronger state cosmetic transparency rules, defines brand owners, suppliers, formulating laboratories, flavor and fragrance companies, and harmful nonfunctional constituents, then requires suppliers to provide brand owners requested safety information within 90 days. That information includes functions and uses, hazards, physical and chemical properties, CAS numbers, exposure and fate data, heavy metal testing, safety data sheets, flow charts, composition statements, allergen statements, IFRA conformity certificates, full fragrance or flavor ingredient lists, finished-product ingredient lists, and certificates of analysis. FDA must create a list of nonfunctional constituents known or expected to be present in cosmetics and harmful to human health or the environment, publish a proposed list, allow 60 days of comment, convene an advisory committee within 9 months, finalize the initial list within 18 months, and update it at least annually. Suppliers must test for listed nonfunctional constituents within one year of listing and provide certificates of analysis before sale. FDA can demand manufacturer, supplier, retailer, and distribution information for suspected adulterated or misbranded cosmetics, and violations can draw civil penalties up to $10,000 per day.
Who Benefits and How
Brand owners benefit from a legal right to obtain ingredient, hazard, testing, and supplier information needed to substantiate cosmetic safety. Cosmetic consumers benefit if better supply-chain data helps identify adulterated, misbranded, contaminated, or hazardous products. State cosmetic regulators benefit because the bill preserves stronger state transparency and disclosure rules. Public health researchers benefit from FDA lists and advisory processes identifying harmful nonfunctional constituents in cosmetics.
Who Bears the Burden and How
Ingredient suppliers must provide detailed safety, hazard, composition, fragrance, flavor, testing, and certificate information within statutory timelines. FDA must create and maintain the nonfunctional-constituent list, manage public comment, convene an advisory committee, and enforce recalls or information requests. Cosmetic supply-chain entities must maintain records sufficient to identify manufacturers, suppliers, retailers, and distribution channels. Violators of supplier-information, testing, notification, nondistribution, or recall rules face civil penalties up to $10,000 for each day of violation.
Key Provisions
- Requires suppliers to provide brand owners requested safety and ingredient information within 90 days.
- Directs FDA to publish a proposed nonfunctional-constituent list, allow 60 days of comment, convene an advisory committee within 9 months, and finalize the initial list within 18 months.
- Requires suppliers to test for listed nonfunctional constituents within one year and provide certificates of analysis before sale.
- Requires supply-chain records and FDA-requested information for suspected adulterated, misbranded, or otherwise unlawful cosmetics.
- Provides civil penalties of up to $10,000 per day for violations of the new supplier-information, testing, notification, nondistribution, and recall rules.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Creates a cosmetic supply-chain transparency regime requiring suppliers to give brand owners safety, ingredient, contaminant, testing, manufacturer, recall, and chain-of-custody information, backed by FDA lists and civil penalties.
Key Policy Areas
Cosmetics, Supply Chain, FDA
Primary Purpose
Creates a cosmetic supply-chain transparency regime requiring suppliers to give brand owners safety, ingredient, contaminant, testing, manufacturer, recall, and chain-of-custody information, backed by FDA lists and civil penalties.
Policy Domains
Resolution provisions
Identified Gains
- Brand owners
- Cosmetic consumers
- State cosmetic regulators
- Public health researchers
Identified Costs
- Ingredient suppliers
- Food and Drug Administration
- Cosmetic supply-chain entities
- Violators of cosmetic transparency rules
Sponsors
Legislative Progress
In CommitteeMs. Schakowsky (for herself, Mrs. Dingell, Mr. Evans of Pennsylvania, …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Brand owners, Cosmetic supply-chain entities, Ingredient suppliers
Food and Drug Administration, State cosmetic regulators
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology